We are going to have a briefing session on Anyfusion V100 at Osaka and Shizuoka, Tokyo University Hospital, Pediatrics Hospital, and National Children's Health Development Center as shown below.

September 21 15:00 Osaka University

September 22 10:00 Shizuoka Children's Hospital 

                        14:00 ~ 17: 00 National Center for Child Health and Development (hospital)

On September 21st and 22nd, the hospital will be holding a product briefing session with the hospital engineer.

Japan has Terumo, one of the five major pharmaceutical injection pumps in the world, supplying it worldwide.

Based on this product briefing, we will do our best together with related companies to demonstrate competitiveness of Anyfusion and to change the paradigm of Japanese drug injection pump market.

Japanese C company has been trading in EZ Regular for 10 years, starting at several thousand for the first year and now growing to tens of thousands.

In fact, Japanese hospitals did not use regulators like EZ Regulator at all, but C company is a successful example that has been imported and grown 40 times for about 10 years.

C company, like H.O.R in Saudi Arabia, has built a reputation in EZ Regular. Even though there are five major majors in the world, we are very excited about the marketization of Anyfusion. Successful marketization will give a big message to the five major majors Terumo.

Although medical devices developed in Korea are in a disadvantageous position in terms of conservatism, rejection of Korean products, reliability, and technology level, they will have sufficient competitiveness to compete with major companies, and the message to the global market is expected to be large due to successful marketization.

Thank you very much to C company for making it a successful place!